Legato Capital Management LLC Decreases Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Legato Capital Management LLC cut its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 30,769 shares of the company's stock after selling 9,642 shares during the period. Legato Capital Management LLC owned 0.05% of Phreesia worth $774,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of PHR. Champlain Investment Partners LLC raised its position in shares of Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after purchasing an additional 97,847 shares during the period. Franklin Resources Inc. raised its holdings in Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock worth $31,495,000 after buying an additional 42,973 shares during the period. State Street Corp lifted its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after buying an additional 88,517 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after buying an additional 55,934 shares during the period. Finally, TimesSquare Capital Management LLC increased its position in shares of Phreesia by 2.3% during the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company's stock worth $19,791,000 after acquiring an additional 19,395 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Phreesia

In related news, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71. Following the sale, the senior vice president now owns 115,633 shares of the company's stock, valued at approximately $3,076,994.13. This represents a 1.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Balaji Gandhi sold 4,813 shares of the company's stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $27.48, for a total value of $132,261.24. Following the sale, the chief financial officer now owns 144,933 shares in the company, valued at approximately $3,982,758.84. This represents a 3.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 167,173 shares of company stock worth $4,221,400. Company insiders own 5.80% of the company's stock.

Phreesia Stock Down 0.7 %

NYSE PHR traded down $0.21 during trading hours on Monday, hitting $29.80. The company's stock had a trading volume of 492,773 shares, compared to its average volume of 353,764. The company has a market capitalization of $1.73 billion, a PE ratio of -20.27 and a beta of 0.96. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company's 50-day simple moving average is $26.77 and its two-hundred day simple moving average is $23.64.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm's quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.58) EPS. Research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on PHR. Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and raised their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. KeyCorp lifted their target price on Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 8th. Needham & Company LLC reissued a "buy" rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Piper Sandler reissued an "overweight" rating and set a $33.00 target price (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Finally, Citigroup boosted their price target on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, January 10th. Thirteen investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $31.15.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.